Although our model is not fully adapted to follow the dynamics of the mouse NASH model due to the slow release of diet-induced TGFβ1, we showed that the observation of iHSC accumulation is supported by the enrichment of iHSC gene signature in NASH patients with increased fibrosis. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.